일본의 체외진단(IVD) 시장 보고서 : 검사 유형, 제품, 유용성, 용도, 최종사용자, 지역별(2025-2033년)
Japan In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2025-2033
상품코드 : 1609665
리서치사 : IMARC
발행일 : On Demand Report
페이지 정보 : 영문 115 Pages
 라이선스 & 가격 (부가세 별도)
US $ 2,999 ₩ 4,470,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트 등의 Copy&Paste도 불가능합니다.
US $ 3,999 ₩ 5,961,000
PDF & Excel (5 User License) help
PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,999 ₩ 7,452,000
PDF & Excel (Corporate License) help
PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

일본의 체외진단(IVD) 시장 규모는 2024년 50억 달러로 추정됩니다. 향후 IMARC 그룹은 2033년까지 시장 규모가 62억 1,000만 달러에 달하고, 2025년부터 2033년까지 2.4%의 연평균 성장률(CAGR)을 나타낼 것으로 예측했습니다. 노인 인구 증가, 급속한 기술 발전, 헬스케어에 대한 인식 증가, 정부 이니셔티브 증가, 맞춤형 약물 요법 개발, 연구개발(R&D) 활동 강화 등이 시장을 이끄는 주요 요인으로 꼽힙니다.

본 보고서에서 다룬 주요 질문

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 일본의 체외진단(IVD) 시장 : 서론

제5장 일본의 체외진단(IVD) 시장 구도

제6장 일본의 체외진단(IVD) 시장 : 검사 유형별 분석

제7장 일본의 체외진단(IVD) 시장 : 제품별 분석

제8장 일본의 체외진단(IVD) 시장 : 사용성별 분석

제9장 일본의 체외진단(IVD) 시장 : 용도별 분석

제10장 일본의 체외진단(IVD) 시장 : 최종사용자별 분석

제11장 일본의 체외진단(IVD) 시장 : 경쟁 구도

제12장 주요 기업 개요

제13장 일본의 체외진단(IVD) 시장 - 업계 분석

제14장 부록

LSH
영문 목차

영문목차

The Japan in vitro diagnostics market size reached USD 5.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.21 Billion by 2033, exhibiting a growth rate (CAGR) of 2.4% during 2025-2033. The rising geriatric population, rapid technological advancements, growing healthcare awareness, increasing government initiatives, development of personalized medication, enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.

In vitro diagnostics (IVD) is a collection of medical tests performed using biological samples from the human body. These tests detect diseases, infections, and other medical conditions by analyzing blood, urine, or tissue samples outside the living organism. They are utilized in laboratories, hospitals, and specialized clinics and are vital in medical decision-making, patient monitoring, and personalized treatment. The increasing adoption of IVD in healthcare supports early diagnosis and precise treatment, allowing healthcare providers to make informed and timely decisions. As an essential component of modern healthcare systems, IVD contributes to the advancement of preventive and therapeutic care, enhancing overall patient well-being. It also improves healthcare efficiency, promoting early detection and reducing healthcare costs. It is also employed in monitoring chronic illnesses and assisting in therapeutic decision-making.

Japan In Vitro Diagnostics Market Trends:

The rising geriatric population necessitating more comprehensive and routine medical testing is one of the major factors contributing to the market growth. In line with this, the increasing prevalence of age-related diseases, such as diabetes, cardiovascular conditions, and cancer, prompting increased IVD tests to diagnose and manage these ailments, is propelling the market growth. Additionally, rapid technological advancements in IVD that are introducing innovative solutions with higher accuracy and efficiency, such as innovations in molecular diagnostics, point-of-care (POC) testing, and automation technologies, enhancing the precision, speed, and accessibility of IVD tests, are also creating a positive outlook for the market growth. In addition to this, the increasing government initiatives promoting healthcare innovation and the introduction of user-friendly, personalized IVD solutions are also positively impacting the market growth. Moreover, the growing awareness and emphasis on preventive healthcare as consumers are increasingly proactive in managing their health, leading to higher demand for wellness-related diagnostic tests and personalized medicine solutions, is acting as a growth-inducing factor. Furthermore, the sudden shift towards personalized medicine and the development of molecular diagnostics are shaping the future of the IVD market in Japan. Besides this, the increasing focus on research and development (R&D) and partnerships between diagnostics companies and research institutions are providing remunerative growth opportunities for the market. In addition to this, the integration of big data and artificial intelligence (AI) in diagnostics, enhancing analytical capabilities, and personalizing care is providing remunerative opportunities for the market growth.

Japan In Vitro Diagnostics Market Segmentation:

Test Type Insights:

Product Insights:

Usability Insights:

Application Insights:

End User Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Japan In Vitro Diagnostics Market - Introduction

5 Japan In Vitro Diagnostics Market Landscape

6 Japan In Vitro Diagnostics Market - Breakup by Test Type

7 Japan In Vitro Diagnostics Market - Breakup by Product

8 Japan In Vitro Diagnostics Market - Breakup by Usability

9 Japan In Vitro Diagnostics Market - Breakup by Application

10 Japan In Vitro Diagnostics Market - Breakup by End User

11 Japan In Vitro Diagnostics Market - Competitive Landscape

12 Profiles of Key Players

13 Japan In Vitro Diagnostics Market - Industry Analysis

14 Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기